Histopathology and clinical assessment correlate with the Cysteine- Serine-Valine-Threonine-Cysteine-Glycine (CSVTCG) receptor of thrombospondin- 1 in breast tumors

Histology and Histopathology

Volumn 12, Issue 4, 1997, Pages 1013-1018

  Roth, J J ^a   Reiver, D M ^a   Granick, M S ^a   Rothman, V L ^a   Nicosia, R F ^a   Tuszynski, G P ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Breast tumors; Cancer; CSVTCG receptor; Immunohistochemistry; Thrombospondin 1

Indexed keywords

RECEPTOR; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 1 RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BREAST TUMOR; CANCER CLASSIFICATION; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; METASTASIS; PATHOGENESIS;

BREAST NEOPLASMS; CARCINOMA; DISEASE PROGRESSION; EPITHELIUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; THROMBOSPONDIN 1;

EID: 0030861551     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Arnoletti J.P., Albo D., Niraq J., Granick M.S, Solomon M.P., Atkinson B., Rothman V.L. and Tuszynski G.P. (1994). Computer assisted image analysis of tumor sections for a new thrombospondin receptor. Am. J. Surg. 168, 433-436.
2. Aznavoorian S., Murphy A.N., Stetler-Stevenson W.G. and Liotta L.A. (1993). Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368-1383.
3. Castle V., Varani J., Fligiel S., Prochownik E.V. and Dixit V. (1991). Antisense-mediated reduction in thrombospondin reversed the malignant phenotype of a human squamous carcinoma. J. Clin Invest. 87, 1883-1888.
4. Harris J.R., Lippman M.E., Veronesi U. and Willett W. (1992). Breast cancer. N. Eng. J. Med. 327, 319-480.
5. Hosokawa T., Muraishi A., Rothman V.L, Papale M. and Tuszynski G.P. (1993). The effect of thrombospondin in invasion of fibrin gels by human A549 lung carcinoma. Oncol. Res. 5, 183-189.
6. Jaffe E.A., Ruggiero J.T., Leung L.L.K., Doyle M.Y., McKeown-Longo P.J. and Mosher D.F. (1986). Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc. Natl. Acad. Sci. USA 80, 998-1002.
7. McPherson J. Sage H. and Bornstein P. (1981). Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin. J. Biol. Chem. 256, 11330-11336.
8. Mosher D.F. (1990). Physiology of thrombospondin. Annu. Rev. Med. 41, 85-97.
9. Nicosia R.F. and Tuszynski G.P. (1994). Matrix bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124, 183-193.
10. Pratt D.A, Miller W.R. and Dawes J. (1989). Thrombospondin in malignant and non-malignant breast tissue. Eur. J. Cancer Clin. Oncol. 25, 343-345.
11. Tarboletti G., Roberts D., Liotta L.A. and Givazzi R. (1990). Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth. A potential angiogenesis regulatory factor. J. Cell Biol. 11, 765-772.
12. Tuszynski G.P. (1993). The role of thrombospondin in tumor cell metastasis. In: Thrombospondin. Lahav J. (ed). The CRC Press Inc. Boca Raton, FL. pp 209-221.
13. Tuszynski G.P. and Nicosia R.F. (1994). Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine specific receptor in human breast carcinoma. Lab. Invest. 70, 228-233.
14. Tuszynski G.P. and Nicosia R.F. (1996). The role of thrombospondin-1 in tumor progression and angiogenesis. BioEssays 18, 71-76.
15. Tuszynski G.P., Rothman V.L., Deutch A.H., Hamilton B.K. and Eyal J. (1992). Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins. J. Cell Biol. 116, 209-217.
16. Tuszynski G.P, Rothman V.L, Papale M., Hamilton B.K. and Eyal J. (1993). Identification of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J. Cell Biol. 120, 513-521.
17. Varani J., Riser B.L, Hughes L.A, Carey T.E., Fligiel S.E.G. and Dixit V.M. (1989). Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin. Exp. Metast. 7, 265-276.
18. Wang T.N., Qian X., Granick M.S., Solomon M.P., Rothman V.L. and Tuszynski G.P. (1995). The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen. Am. J. Surg. 170, 502-505.
19. Wang T.N., Qian X., Granick M.S., Solomon M.P., Rothman V.L., Berger D.H. and Tuszynski G.P. (1996). Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor. Surgery 100, 450-454.
20. Wong S.Y., Purdie A.T. and Han P. (1992). Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am. J. Pathol. 140, 1473-1482.
21. Yabkowitz R., Mansfield P.J., Dixit V.M. and Suchard S.J. (1993). Motility of human carcinoma cells in response to thrombospondin, relation to metastatic potential and thrombospondin structural domains. Cancer Res. 53, 378-387.